About
Create, test, validate and deploy AIs at any level of complexity – without writing a single line of code. Whether it’s a chatbot, email categorisation agent, or medical diagnostic – Jiva.ai has all the processes and tools to be able to create a solution.
AI and data science is generally difficult skillset to hire and therefore building AI and data science-led solutions can often be expensive and take a long time. Jiva.ai makes machine learning projects as easy as writing an email. Subject matter experts can create their AI solutions without having to be data or machine learning gurus. Jiva.ai democratises access to multimodel and agentic AI in a user friendly way.
As an illustration, in an InnovateUK project we created a liver disease diagnostic the traditional way (coding, data science resources) and the Jiva.ai way (on our platform). The former took 9 months to create a high fidelity medical diagnostic. The latter only took 3 days to build on the platform. Now, it only takes minutes.
Jiva.ai’s core USP is our patented multiagent technology that enables us to merge multiple AI models together – a process that cannot be replicated with traditional AI tech such as those used by the majority of competitors. This means that Jiva.ai can grow AI solutions rather than start from scratch when new knowledge/data is discovered. This is particularly useful in healthcare where data is often incomplete.
Key Facts
✔ Proven to bring down development time by >90%
✔ Proven to be extremely cost effective, saving >87% on costs
✔ Cross-industry, multiple use-case support
✔ Simple SaaS model
✔ Client retains all foreground IP
Successes in UK/NHS
Jiva.ai has made significant strides in the UK healthcare sector, particularly within the NHS, through its innovative AI platform designed to enhance diagnostic accuracy and efficiency. Their flagship product, JivaRDX, focuses on improving prostate cancer diagnostics by analyzing MRI scans to identify potential tumors. Clinical evaluations conducted across Hywel Dda University Health Board demonstrated that JivaRDX achieved a sensitivity of 77% and specificity of 65%, outperforming traditional radiologist assessments in specificity. This advancement has the potential to reduce unnecessary biopsies and associated complications, leading to better patient outcomes and cost savings for the NHS . Beyond prostate cancer, Jiva.ai's platform is being applied to other areas such as liver disease detection and bone fracture analysis, showcasing its versatility in handling various healthcare challenges . The company's commitment to integrating AI into clinical workflows has been recognized through partnerships with NHS institutions and support from initiatives like the Moondance Cancer Initiative . With ongoing collaborations and a focus on expanding its AI capabilities, Jiva.ai continues to contribute to the modernization and improvement of healthcare services in the UK.Company details
Solutions
Enabling core infrastructure
Specialism
Libraries and marketplaces
Company details
Want to connect with this innovator?
Make an enquiryWebsite
www.jiva.ai/Markets already exporting to
UK, USA
Desired Markets
GCC, EU
Desired customer types
Enterprise, Government, SME